Aptevo falls after record gains day before, retail interest persists

Aptevo Therapeutics

24/11/2021 13:13

** Shares in biotech co Aptevo Therapeutics  APVO.O  drop
27.6% to $12.33 premarket
    ** APVO trending at No. 4 on retail investor-focused social
media platform Stocktwits.com, with message volume up 4,125%
    ** Co reported its best day on Tuesday after preliminary
data showed one high-risk cancer patient treated with its drug
and chemotherapy achieved complete remission after one cycle of
treatment  urn:newsml:reuters.com:*:nL4N2SE2MA
    ** APVO was the sixth most traded stock on Fidelity's
trading app on Tuesday, indicating retail investors' interest
    ** Both brokerages covering APVO rate the stock "buy" 
    ** Stock down 53.5% this year, as of last close

 (Reporting by Bansari Mayur Kamdar)
 ((BansariMayur.Kamdar@thomsonreuters.com;))